New Key Statistics Module, Z-Score and F-Score
NAS:MEDS Key Ratios
Market Cap $ M | 8.87 |
Enterprise Value $ M | 15.83 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 10.53 |
Price/Sales | 0.75 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 8.00 |
EPS (TTM) $ | -23.22 |
Beneish M-Score | -1.19 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.22 |
EV-to-EBITDA | -1.33 |
PEG | -- |
Shares Outstanding M | 1.41 |
Net Margin (%) | -200.85 |
Operating Margin % | -86.78 |
Pre-tax Margin (%) | -159.27 |
Quick Ratio | 0.24 |
Current Ratio | 0.24 |
ROA % (ttm) | -195.86 |
ROE % (ttm) | -731.86 |
ROIC % (ttm) | -73.68 |
Dividend Yield % | -- |
Altman Z-Score | -6.82 |
MEDS Number of Guru Trades
MEDS Volume of Guru Trades
Gurus Latest Trades with NAS:MEDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MEDS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Trxade Health Inc Insider Transactions
No Available Data
News about NAS:MEDS
Total 0- 1